Abstract:Human immunodeficiency virus (HIV-1 or simply HIV) induces a persistent infection, which in the absence of treatment leads to AIDS and death in almost all infected individuals. HIV infection elicits a vigorous immune response starting about 2-3 weeks post infection that can lower the amount of virus in the body, but which cannot eradicate the virus. How HIV establishes a chronic infection in the face of a strong immune response remains poorly understood. It has been shown that HIV is able to rapidly change its proteins via mutation to evade recognition by virus-specific cytotoxic T lymphocytes (CTLs). Typically, an HIV-infected patient will generate 4-12 CTL responses specific for parts of viral proteins called epitopes. Such CTL responses lead to strong selective pressure to change the viral sequences encoding these epitopes so as to avoid CTL recognition. Here we review experimental data on HIV evolution in response to CTL pressure, mathematical models developed to explain this evolution, and highlight problems associated with the data and previous modeling efforts. We show that estimates of the strength of the epitope-specific CTL response depend on the method used to fit models to experimental data and on the assumptions made regarding how mutants are generated during infection. We illustrate that allowing CTL responses to decay over time may improve the fit to experimental data and provides higher estimates of the killing efficacy of HIV-specific CTLs. We also propose a novel method for simultaneously estimating the killing efficacy of multiple CTL populations specific for different epitopes of HIV using stochastic simulations. Lastly, we show that current estimates of the efficacy at which HIV-specific CTLs clear virus-infected cells can be improved by more frequent sampling of viral sequences and by combining data on sequence evolution with experimentally measured CTL dynamics.

An Efficient Therapy Strategy under a Novel HIV Model

Evolutionary Game Theoretic Strategy for Optimal Drug Delivery to Influence Selection Pressure in Treatment of HIV-1

A New Mathematical Model for Assessing Therapeutic Strategies for HIV Infection

Optimizing HIV/AIDS Dynamics: Stochastic Control Strategies with Education and Treatment

Conflict and Accord of Optimal Treatment Strategies for HIV Infection Within and Between Hosts.

Towards a New Combination Therapy with Vectored Immunoprophylaxis for HIV: Modeling "shock and Kill" Strategy.

Modelling the Transmission Dynamics and Optimal Control Strategies for HIV Infection in China

Dynamic multidrug therapies for HIV: A control theoretic approach

Global Stability and Persistence of HIV Models with Switching Parameters and Pulse Control

Hiv-1 Population Dynamics in Vivo: Implications for Pathogenesis, Effect of Cytokine and Therapy Strategy

Optimal Control Control Of Drug Therapy: Melding Pharmacokinetics With Viral Dynamics

Optimal Control Strategies and Sensitivity Analysis of an HIV/AIDS-Resistant Model with Behavior Change

Model-free based control of a HIV/AIDS prevention model

A Piecewise Model of Virus-Immune System with Effector Cell-Guided Therapy

Modeling HIV Dynamics Under Combination Therapy with Inducers and Antibodies

Piecewise HIV Virus Dynamic Model with CD4(+) T Cell Count-Guided Therapy: I.

HIV Infection Dynamics with Broadly Neutralizing Antibodies and CTL Immune Response

Transmission dynamics and optimal control strategies in a multi-pathways delayed HIV infection model with multi-drug therapy

Viral dynamics model with CTL immune response incorporating antiretroviral therapy

Mathematical modeling of escape of HIV from cytotoxic T lymphocyte responses

Modeling of HIV-1 Infection: Insights to the Role of Monocytes/Macrophages, Latently Infected T4 Cells, and HAART Regimes